Recent studies indicate that eosinophils may either promote anti-tumor immunity, by enhancing CD8<sup>+</sup> T cell infiltration, secreting cytotoxic granules, and cooperating with IL-33, or facilitate tumor progression through recruitment of regulatory T cells, immune suppression, and expression of immunoregulatory enzymes like IDO. The gene discussed is IDO1; the disease is neoplasm.